Predicting Factors Affecting Glucose Monitoring Treatment Satisfaction and Drug Attitude Inventory (Adherence) Among Patients with Type 2 Diabetes Mellitus; Cross-sectional Observational Study

Author(s): Syed Ata ur Rahman*.

Journal Name: Current Diabetes Reviews

Volume 15 , Issue 3 , 2019

Become EABM
Become Reviewer

Abstract:

Objectives: The study aimed to explore the predictors affecting patient satisfaction to glucose monitoring system (GMSS) and drug attitude inventory (DAI) / treatment adherence among type 2 diabetes mellitus patients.

Methods: Cross-sectional observational study design was used to conduct this study. Subjective assessments were made by questionnaires and objective data was collected from the patients' medication profiles registered to diabetic clinics. Patients were recruited from five different public hospitals of Hyderabad region, India. A total of 430 patients completed for analysis. The predictors to GMSS dimensions and adherence status were analyzed with Wilks's lambda effect and multivariate generalized linear model (GLM/MANOVA).

Results: Study population consisted of 64.4% males and 35.6% females, age mean ± SD (43.3±11.42) years, majority of the study of participants were in between 40-60 years of age (53.3%). Majority of participants were considered healthy on BMI scale (67.2%), in contrast 234 (54.4%) reported high glycemic index with Hb1Ac (> 7.5%). Descriptive distribution pattern showed 241 (56.1%) participants were moderately satisfied with the current monitoring system. However, 157 (36.5%) reported poor satisfaction to GMSS scale score. Findings showed that low mean score of openness and worthwhileness are reported among nonadherent participants. Behavioral burden significantly high among nonadherent patients then adherents. However, emotional burden showed no effect on treatment adherence.

Conclusion: This study found high rates of poor glucose monitoring system satisfaction along with low-to-poor treatment adherence among T2DM patients. Individual characteristics and clinical parameters significantly and positively predict the variance of GMSS and DAI among patients' with T2DM.

Keywords: Type 2 diabetes mellitus, treatment satisfaction, medication adherence, glucose monitoring, cross-sectional study, observational study.

[1]
Gillani SW. Determining effective diabetic care; a multicentre - longitudinal interventional study. Curr Pharm Des 2016; 22(42): 6469-76.
[2]
International diabetes federation (IDF), About Diabetes, 2013.http://www.idf.org/about-diabetes [Accessed on: 05-04-2017]
[3]
Gillani SW, Sulaiman SAS, Abdul MIM, Baig MR. Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial. Cardiovasc Diabetol 2017; 16(1): 103.
[4]
Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes 2012; 19(2): 93-6.
[5]
Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23(5): 469-80.
[6]
Gillani SW, Azeem E, Siddiqui A, et al. Oxidative Stress Correlates (OSC) in Diabetes Mellitus Patients. Curr Diabetes Rev 2016; 12(3): 279-84.
[7]
Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94(3): 311-21.
[8]
Gillani SW, Abdul MI. Public health care system, a quasi-experimental study: Acceptance and attitude to implicate clinical services. Acta Pharm 2017; 67(1): 71-83.
[9]
International Diabetes Federation (IDF), South-east Asian Region.India Country profiling. 2017.https://www.idf.org/our-network/regions-members/south-east-asia/members/94-india.html [Accessed on: 10-10-2017].
[10]
Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94(3): 311-21.
[11]
Anjana RM, Ali MK, Pradeepa R, et al. The need for obtaining accurate nationwide estimates of diabetes prevalence in India - rationale for a national study on diabetes. Indian J Med Res 2011; 133: 369-80.
[12]
Zargar AH, Khan AK, Masoodi SR. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res Clin Pract 2000; 47(2): 135-46.
[13]
Arora V, Malik JS, Khanna P, Goyal N, Kumar N, Singh M. Prevalence of diabetes in urban Haryana. Australas Med J 2010; 3(8): 488-94.
[14]
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977-86.
[15]
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-53.
[16]
Khadilkar KS, Bandgar T, Shivane V, Lila A, Shah N. Current concepts in blood glucose monitoring. Indian J Endocrinol Metab 2013; 17(Suppl. 3): S643-9.
[17]
Daniel WW. Biostatistics: basic concepts and methodology for the health sciences. New York: John Wiley & Sons 2010.
[18]
Prevalence of T2DM India: Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014; 7(1): 45-8.
[19]
Indicators and methods for cross-sectional surveys of vitamin and mineral status of populations. The Micronutrient Initiative (Ottawa) and the Centers for Disease Control and Prevention (Atlanta) http://www.who.int/vmnis/ toolkit/mcn-micronutrient-surveys.pdf [Accessed on: 8 January 2017]
[20]
William H. Polonsky, Lawrence Fisher, Danielle Hessler, Steven V Edelman. Development of a new measure for assessing glucose monitoring device-related treatment satisfaction and quality of life. Diabetes Technol Ther 2015; 17(9): 657-63.
[21]
Karthik MS, Warikoo N, Chakrabarti S, Grover S, Kulhara P. Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications. Indian J Psychol Med 2014; 36(3): 288-93.
[22]
Keselman HJ, Huberty CJ, Cribbie RA. Statistical practices of educational researchers: an analysis of their ANNOVA, MANOVA and ANCOVA analysis. Rev Educ Res 1998; 68(3): 350-86.
[23]
Li C, Ford ES, Mokdad AH, Jiles R, Giles WH. Clustering of multiple healthy lifestyle habits and health-related quality of life among US adults and diabetes. Diabetes Care 2007; 30(7): 1770-6.
[24]
Kazemi-Galougahi MH, Ghaziani HN, Ardebili HE, Mahmoudi M. Quality of life in type 2 diabetic patients and related effective factors. Indian J Med Sci 2013; 66(10): 230-7.
[25]
Penckofer S, Quinn L, Byrn M, Ferrans C, Miller M, Strange P. Does Glycemic Variability Impact Mood and Quality of Life? Diabetes Technol Ther 2012; 14(4): 303-10.
[26]
Eljedi A, Mikolajczyk RT, Kraemer A, Laaser U. Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in Gaza strip; a cross-sectional study. BMC Public Health 2006; 6: 268.
[27]
D’Souza MS, Karkada SN, Somayaji G, Venkatesaperumal R. Women’s well-being and reproductive health in indian mining community: need for empowerment. Reprod Health 2013; 9(10): 24.
[28]
Martinez YV, Prado-Aguliar CA, Rascon-Peacheco RA, Valdivia-Martinez JJ. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Serv Res 2008; 8: 164.
[29]
Wang HF, Yeh MC. The quality of life of adults with type 2 diabetes in a hospital care clinic in Taiwan. Qual Life Res 2013; 22(3): 577-84.
[30]
Jayasinghe UW, Harris MF, Taggart J, Christl B, Black DA. Gender differences in health related quality of life of Australian chronically-ill adults: patient and physician characteristics do matter. Health Qual Life Outcomes 2013; 21(11): 102.
[31]
Gazzaruso C, Fodaro M, Coppola A. Structured therapeutic education in diabetes: is it time to re-write the chapter on the prevention of diabetic complications? Endocrine 2016; 53: 347.
[32]
Coppola A, Sasso L, Bagnasco A, Giustina A, Gazzaruso C. The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine 2016; 53(1): 18-27.
[33]
Coppola A, Luzi L, Montalcini T, Giustina A, Gazzaruso C. Role of structured individual patient education in the prevention of vascular complications in newly diagnosed type 2 diabetes: the individual Therapeutic Education in Newly Diagnosed type 2 diabetes (INTEND) randomized controlled trial. Endocrine 2018; 60(1): 46-9.
[34]
He X, Li J, Wang B, et al. Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis. Endocrine 2017; 55(3): 712-31.
[35]
Goodridge D, Trepman E, Embil JM. Health-related quality of life in diabetic patients with foot ulcers: literature review. J Wound Ostomy Continence Nurs 2005; 32(6): 368-77.
[36]
W. Ken Redekop, Marc A. Koopmanschap, Ronald P. Stolk, Guy E.H.M. Rutten, Bruce H.R. Wolffenbuttel, Louis W. Niessen. Health-related quality of life and treatment satisfaction in dutch patients with type 2 diabetes. Diabetes Care Mar 2002; 25(3): 458-63.
[37]
Faria HTG, Veras VS. ATdF X, CRdS T, Zanetti ML, MAD S. Quality of life in patients with diabetes mellitus before and after their participation in an educational program. Revista da Escola de Enfermagem da 2013; 47: 348-54.
[38]
Saleh F, Mumu SJ, Ara F, Hafez MA, Ali L. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health 2014; 14: 31.
[39]
Perwitasari D, Urbayatun S. Treatment adherence and quality of life in diabetes mellitus patients in Indonesia. SAGE Open 2016; 6: 1-7.
[40]
Chaveepojnkamjorn W, Pichainarong N, Schelp F-P, Mahaweerawat U. Quality of life and compliance among type 2 diabetic patients. Southeast Asian J Trop Med Public Health 2008; 39: 328-34.
[41]
Honish A, Westerfield W, Ashby A, Momin S, Phillippi R. Health-related quality of life and treatment compliance with diabetes care. Dis Manag 2006; 9: 195-200.
[42]
Wändell P. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 2005; 23: 68-74.
[43]
Imayama RC. Plotnikoff, K.S. Courneya, J.A. Johnson. Determinants of quality of life in adults with type 1 and type 2 diabetes. Health Qual Life Outcomes 2011; 9: 115.
[44]
Shim YT, Lee J, Toh MP, Tang WE, Ko Y. Health-related quality of life and glycemic control in patients with type 2 diabetes mellitus in Singapore. Diabet Med 2012; 29(8): e241-8.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 3
Year: 2019
Page: [233 - 239]
Pages: 7
DOI: 10.2174/1573399814666180405095540
Price: $58

Article Metrics

PDF: 49
HTML: 3
EPUB: 1
PRC: 2